Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Emerging roles of lymphatic endothelium in regulating adaptive immunity
Catherine M. Card, … , Shann S. Yu, Melody A. Swartz
Catherine M. Card, … , Shann S. Yu, Melody A. Swartz
Published March 3, 2014
Citation Information: J Clin Invest. 2014;124(3):943-952. https://doi.org/10.1172/JCI73316.
View: Text | PDF
Review Series

Emerging roles of lymphatic endothelium in regulating adaptive immunity

  • Text
  • PDF
Abstract

Emerging research on the roles of stromal cells in modulating adaptive immune responses has included a new focus on lymphatic endothelial cells (LECs). LECs are presumably the first cells that come into direct contact with peripheral antigens, cytokines, danger signals, and immune cells travelling from peripheral tissues to lymph nodes. LECs can modulate dendritic cell function, present antigens to T cells on MHC class I and MHC class II molecules, and express immunomodulatory cytokines and receptors, which suggests that their roles in adaptive immunity are far more extensive than previously realized. This Review summarizes the emergent evidence that LECs are important in maintaining peripheral tolerance, limiting and resolving effector T cell responses, and modulating leukocyte function.

Authors

Catherine M. Card, Shann S. Yu, Melody A. Swartz

×

Figure 3

LECs can suppress immunity and promote tolerance in multiple ways.

Options: View larger image (or click on image) Download as PowerPoint
LECs can suppress immunity and promote tolerance in multiple ways.
(A) L...
(A) LECs interact with DCs via binding of ICAM-1 to Mac-1, inhibiting DC maturation and thus dampening their ability to effectively activate T cells. (B) LECs that have been activated by T cell–derived pro-inflammatory cytokines can inhibit T cell proliferation through the production of molecules such as IDO, TGF-β, and NO, which suppress T cell activation. (C) LECs can directly present endogenous PTAs and cross-present exogenous antigens to naive CD8+ T cells to induce dysfunctional T cell activation and tolerance due to expression of the inhibitory receptor PD-L1 and lack of co-stimulatory molecules on the surface of LECs.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts